Anika Therapeutics Inc (ANIK)

EBITDA Margin

2.25%

TTM · Period ending:

ANIK logo

ANIK EBITDA Margin

Latest reported2.25%
ANIK TTM EBITDA Margin (-25.00% → 2.25%)
High-resolution chart · PNG

ANIK ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Anika Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-24.6555%
-8.3694%
1.3123%
-16.0021%
-4.0466%
-0.7651%
7.6544%
11.7507%
16.4217%
28.4722%
29.2857%
38.5542%
37.3333%
31.0078%
30.8333%
-2.8169%
-7.3529%
-27.5862%
-59.1837%
-53.1915%
-65.1163%
-70.2703%
-50%
-50%
-36.1111%
-37.8378%
-34.0909%
-25.5319%
-22.807%
-25%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.